Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Scientific Reports|November 17, 2018
The step-like evolution of Arctic open waterMichael A Goldstein, Amanda H Lynch, Andras Zsom, et al.Journal of Virology|March 28, 2014
The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activityCyril Masante, Farah El Najjar, Andres Chang, et al.Ejhaem|February 13, 2025
Hodgkin Lymphoma Treatment With Brentuximab Vedotin in a Patient With HIV, Liver Failure, and Anemia Without TransfusionEllen Marin, Aseala Abousaud, Kathleen Davis, et al.Blood Cancer Journal|January 8, 2021
Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphomaSelin Merdan, Kritika Subramanian, Turgay Ayer, et al.Journal for Immunotherapy of Cancer|October 26, 2024
Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapyRahul K Nayak, Meili Aiello, Laneisha Marielis Maldonado, et al.Clinical Lymphoma, Myeloma & Leukemia|January 29, 2019
Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell LymphomaAndres Chang, Jackelyn B Payne, Pamela B Allen, et al.Expert Review of Hematology|September 13, 2019
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphomaR Andrew Harkins, Andres Chang, Sharvil P Patel, et al.Transfusion|March 9, 2019
Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patientsChristina L Dean, Cheryl L Maier, Satheesh Chonat, et al.The Journal of Clinical Investigation|July 21, 2022
Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemiaAndres Chang, Anton M Sholukh, Andreas Wieland, et al.Proceedings of the National Academy of Sciences of the United States of America|September 4, 2025
PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapyAndres Chang, Adam N Pelletier, Donald J McGuire, et al.Pageof 3